Provisions for post-trial care {30}
headache
EPILEPTIC SEIZURE
There will be no special procedures following for patients that have completed the trail. Patients will be treated according to the standard of care after the termination of the study. After the last treatment, the subject enters the Follow‐up phase. For patients prematurely terminating the study for one of the above listed reasons, there will be no special follow‐up procedures. In case of a premature termination of therapy, reasons/circumstances and if applicable the final status will be documented. If the patient does not withdraw the consent for further Follow‐up, he/she should be followed‐up as planned. To those who suffer harm from trial participation (e.g., epileptic seizure, headache), the standard treatment for the symptoms that have been arisen will be provided in the hospital.